SmiLe is a full range Life Science Incubator hosting companies from Biomedicine to E-Health and providing pharma development labs and business support. Since start 2008, SmiLe has supported over 60 companies whereof 12 have achieved successful IPOs. In the last four years, our community of startups has attracted over 175 MEURO in venture capital. We see continued success ahead. This is your portal to SmiLe news.
Sign up for SmiLe Insights
SmiLe Insights is a brand new financial and industry newsletter presenting current startup portfolio, news, presentations and coming opportunities from our community. SmiLe startups have consistently achieved growth and success through strong investors and valuable partnerships. Looking forward to continued positive results and a greater community, this publication provides broader access to new startups, companies’ progress, and to financial, licensing and transactional opportunities.
If you are interested in SmiLe news and want to receive the newsletter, please subscribe for SmiLe Insights.
You can also read our recent newsletter online: Newsletter April 2018
Investment opportunities
This list does not cover all issues but highlights some opportunities. The figures are assumptions based on the companies forecasted needs. The final offers will be presented by the companies at launch of their financing efforts.
In2Cure AB
Seeking 10 – 12 MSEK in Q2 to reach clinical phase
www.in2cure.com
Receptor Pharma AB
Seeking first 500 000 SEK now, for initial discovery
www.receptorpharma.com
ImmuneBiotech AB
Seeking 20 MSEK late Q2, for market launch
www.immunebiotech.com
POOW AB
Seeking seed funding in Q2, for global expansion
www.poowapplications.se
Medotemic AB
Seeking seed funding in Q2, for market launch
www.medotemic.se
SmiLe Portfolio
Recent news
Sign up for SmiLe´s newsletter to receive information about our incubator companies